CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Option exercise President and CEO acquired 100,000 shares (option exercise)
- 4 Open-market sale Director sold 12,877 shares at $6.25 ($80,481)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 17,525 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Option exercise Director acquired 13,228 shares (option exercise)
- SD Other Specialized Disclosure
- 4 Open-market sale Director sold 5,000 shares at $5.75 ($28,735)
- 4 Option exercise Chief Scientific Officer acquired 25,200 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 17 of 76 · 1,513 filings